(Q54022571)

23 May 2018

title

Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. (English)

1 reference

23 May 2018

7

Büchler MW

1 reference

23 May 2018

2

Friess H

1 reference

23 May 2018

author name string

Ozawa F

1

1 reference

23 May 2018

Kleeff J

3

1 reference

23 May 2018

Xu ZW

4

1 reference

23 May 2018

Zimmermann A

5

1 reference

23 May 2018

Sheikh MS

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

23 May 2018

published in

Cancer Letters

1 reference

23 May 2018

volume

163

1 reference

23 May 2018

page(s)

71-81

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

Apoptosis: Silencing the death receptors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Functional expression of TRAIL by lymphoid and myeloid tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900660-1

7 January 2021

10.1016/S0304-3835(00)00660-1

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11163110

1 reference

23 May 2018